Click here to view the Cover Story for this Point/Counter.
New classes of medication? What would you need? One that is safer than latanoprost, lasting weeks at a time, no ophthalmic adverse events and more comfort than currently available medications. Also, a new mechanism of action would be a plus. This bar is one that is hard to reach, one that is hard to imagine can be achieved within the next few decades after the upcoming introduction of Rho kinase inhibitors.
What is really needed is a way to put (Read more...)
Uncategorized